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CHAPTER 1: INTRODUCTION
Background
Due to widespread stigmatization of the transgender population and cultural
assumptions about gender (Bauer et al., 2009), most healthcare providers and medical staff have
not received adequate training to meet the unique needs of this marginalized group (Advisory
Committee on Sexual Orientation, 2014; Sanchez, Rabatin, Sanchez, Hubbard, & Kalet, 2006).
Consistent with trends towards patient-centered care and shared decision-making (Sheridan,
Harris, Woolf, & Force, 2004; Stiggelbout et al., 2012), professional organizations and others
have recently released policy and practice recommendations for providing culturally competent
care to transgender patients (Advisory Committee on Sexual Orientation, 2014; Legal, 2014).
Yet, very little is known about healthcare providers’ experience of providing care to transgender
patients, their attitudes and knowledge about transgender health, their willingness to serve this
population, or how the health system context influences physicians’ capacity to provide
transgender-sensitive care.
According to the National Association of Social Workers’ (NASW) Code of Ethics,
addressing discrimination that is based on gender identity or expression is one obligation of the
social work profession (National Association of Social Workers, 2008), and the experiences of
bias that transgender individuals face when seeking medical attention suggest that there are
major disparities in healthcare access and quality for this population. In one national study,
nearly one quarter of transgender individuals reported being denied health care services
outright, and nearly half of transgender patients who did receive care did not reveal their gender
identity status to their healthcare providers or disclosed to only some providers due to fears of
experiencing bias or being denied care (Grant et al., 2011). Thus, it is not surprising that
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transgender individuals report delaying or avoiding seeking care for illnesses or injuries (Grant,
Mottet, & Tanis, 2010) and may seek health care only for gender transition-related services
(Jenner, 2010).
This study used an adapted Theory of Planned Behavior to examine health care
providers’ willingness to care for transgender individuals. Specifically, the purpose of this study
was to examine factors associated with primary care and women’s health providers’ willingness
to provide both routine and transition care for transgender patients. Findings from this study
can be used to 1) identify high priority health system policy and procedural changes that are
likely to have the greatest impact on transgender care quality; 2) design interventions for
healthcare personnel; 3) point to implications for medical education; and 4) identify avenues
for social work professionals to advocate for this marginalized population.
Study Aims
Transgender individuals face a number of barriers when accessing healthcare, and there
are a number of gaps in the literature related to healthcare providers’ willingness to provide
routine and transition care to this population. Thus, the aims of this study are as follows:
1. To determine the association between provider characteristics, personal and
clinical exposure, transphobia, empathetic attitudes towards transgender patients,
and transgender care-related self-efficacy on willingness to provide routine care to
transgender patients.
H1: When provider characteristics are controlled, increased personal and clinical
exposure, decreased transphobia, increased empathy attitudes, increased selfefficacy will be positively associated with willingness to provide routine care to
transgender individuals.
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2. To determine the association between provider characteristics, personal and
clinical exposure, transphobia, empathetic attitudes towards transgender patients,
and transgender care-related self-efficacy on willingness to continue hormone
therapy for transgender patients.
H2: When provider characteristics are controlled, increased personal and clinical
exposure, decreased transphobia, increased empathetic attitudes, increased selfefficacy, and increased facilitators will be positively associated with willingness to
continue hormone therapy for transgender individuals.
3. To determine the association between provider characteristics, personal and
clinical exposure, transphobia, empathetic attitudes towards transgender patients,
and transgender care-related self-efficacy on willingness to initiate hormone
therapy for transgender patients.
H2: When provider characteristics are controlled, increased personal and clinical
exposure, decreased transphobia, increased empathy attitudes, and increased selfefficacy will be positively associated with willingness to initiate hormone therapy
for transgender individuals.
Significance
This study is the first to explore factors that predict healthcare providers’ willingness to
provide both routine and transition care to transgender individuals. By leveraging well
established constructs that predict behavioral intentions (i.e., the Theory of Planned Behavior),
this study is well positioned to provide unique insight into what barriers and facilitators (i.e.,
factors related to self-efficacy) limit healthcare providers’ willingness to care for transgender
patients as well as how to alleviate those barriers. Findings from this study will inform where
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best to intervene with medical professionals in order to improve health care quality for the
transgender population, in terms of education, training, policies, procedures, and health system
culture.
Social Work Implications
Social workers can increasingly be found providing care to patients in medical settings.
Knowing barriers that healthcare providers may face in providing care to transgender patients
is critical for social workers who are part of healthcare teams. Social workers are well
positioned to advocate for vulnerable populations, and increasing evidence suggests that
transgender persons are at risk for being denied basic health care as well as transition services,
which may be critical for their wellbeing. Results of this study may point to the importance of
the advocacy role that social workers can play in medical settings on behalf of vulnerable
populations. In addition, social workers may often play a role either in providing counseling or
therapy to transgender individuals, and they may also be in a position to assist in the
coordination of medical transition care.
In addition, social workers are at the forefront of developing cultural competence
trainings, guidelines, and curricula, and are also in a position to provide training, education, and
advocacy in medical settings. As social workers have become more involved in providing
services in integrated healthcare settings, they will also become more involved in ensuring that
medical care is culturally competent and equitable. The NASW Code of Ethics specifies that
addressing discrimination due to gender identity (among other marginalized statuses) is one
obligation of the social work profession (National Association of Social Workers, 2008).
Nowhere is this need more critical than in the availability of basic and transition health care for
transgender individuals.
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CHAPTER 2: LITERATURE REVIEW
The transgender population can be defined as those who identify conflict between their
current gender identity and their assigned sex at birth (Kenagy, 2005). Although the transgender
population is diverse in terms of gender identity, it may include both individuals who were
assigned male at birth but identify as female (MTF) as well as those who were assigned female
at birth but identify as male (FTM). The transgender population is arguably one of the most
marginalized minority groups in the United States. In this chapter, the health care needs of the
transgender population and healthcare discrimination experiences reported by transgender
patients will be explored. In addition, provider-level factors, including transgender-care related
self-efficacy, affecting care delivery to the transgender population will be described. Finally,
gaps in the literature will be elucidated, particularly as they pertain to healthcare providers’
willingness to provide both routine care and medical transition care for the transgender
population.
Healthcare Needs of the Transgender Population
Medical Transition Care
Many transgender individuals either seek or would like to seek some type of transition
care so that their physical characteristics and presentation match their gender identity
(Davidson, 2007). Transition care may involve a number of different services, procedures, and
medications, including hair removal, cosmetic changes, and voice coaching. Medical transition
care generally includes counseling, cross-sex hormone treatment, and/or surgery. Several
organizations have published guidelines to direct health and mental health providers in assisting
patients with the transition process, including the Endocrine Society (Hembree et al., 2009) and
the World Professional Association of Transgender Health or WPATH (Coleman et al., 2012).
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These guidelines are based on expert opinion and give guidance on the transition process,
including both mental health care and transition care. The transition process involves five
progressive stages, some of which may happen concurrently, and not all transgender individuals
complete every stage. These stages include 1) diagnosis of gender dysphoria by a licensed
mental health professional; 2) counseling; 3) real-life experience living as one’s non-birth sex;
4) cross-sex hormone treatment; and 5) surgery (Wilczynski & Emanuele, 2014).
Available surgeries for transgender men and women include procedures such as facial
feminization (for transwomen), chest surgery (breast removal or breast augmentation),
hysterectomy (for transmen) and alteration of genitalia (metoidioplasty, scrotoplasty,
phalloplasty, orchiectomy, and vaginoplasty) (Erickson‐Schroth, Bowers, & Carmel, 2015).
Somewhat more accessible in terms of both cost and availability – and more commonly used
(Grant et al., 2011) - is cross-sex hormone treatment. Hormone treatment for FTM patients
includes testosterone injections given at regular intervals (usually every two weeks), sometimes
with complementary androgen gel or patches. The goal of hormone treatment for FTM patients
is essentially to induce virilization (lower voice, cessation of menses, and produce male-pattern
hair growth) (Gooren, 2014). For transgender women, hormone treatment includes the use of
either oral or transdermal estrogen, with the goal of changing body fat distribution, reducing
hair growth, and feminizing body shape (i.e., breast augmentation) (Wierckx et al., 2012).
Cross-sex hormone treatment may be particularly important for transgender individuals,
as multiple studies have identified positive mental health effects of such treatment. One
longitudinal study found significant improvements in depression, anxiety, psychological
symptoms, and functional impairment at one year after the onset of cross-sex hormone
treatment for transgender individuals (Colizzi, Costa, & Todarello, 2014). Another study of
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transwomen in San Francisco found that use of transition-related medical care (hormone
treatment) was associated with lower risk of binge drinking, drug use, and suicidal ideation,
suggesting that transition care may reduce mental health and behavioral risks among this
population (Wilson, Chen, Arayasirikul, Wenzel, & Raymond, 2015). The same is true of
samples of transmen; a prospective study found that three months of hormone treatment was
associated with better quality of life and mental health compared to a control group (Keo-Meier
et al., 2015). The documented positive effects of hormone therapy for transitioning individuals
points to the importance of the availability of this type of care.
A number of medical professionals are involved in the transition process, but “family
and internal medicine physicians continue to deliver the care in the long term” (Wilczynski &
Emanuele, 2014, p. 121). Hormone therapy is both beneficial and straightforward and can be
provided by primary care physicians and as well as other providers (Gardner & Safer, 2013).
For example, patients being treated with hormones require routine lab monitoring to ensure
optimal hormone levels as well as annual renal and liver function tests, among others, to
determine whether adverse effects require changes in hormone regimens – all of which is
routinely ordered by primary care providers (Wilczynski & Emanuele, 2014).
Routine Care
In addition to transition care, transgender individuals require basic routine medical
care for illnesses or injuries, for the treatment of chronic diseases such as diabetes or cancer,
as well as preventive care such as cancer screenings and blood pressure monitoring. However,
hormone use, surgeries, and other medical transition steps may affect their healthcare needs in
a way that is unique. For example, because Prostate Specific Antigen (PSA) levels are low
when testosterone levels are low, a PSA test is not an appropriate screening mechanism for
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prostate cancer for transwomen on transition hormone regimens – digital rectal exams are
recommended instead (Center of Excellence for Transgender Health, 2011). In addition,
testosterone use may increase the incidence of polycystic ovarian syndrome among transmen
(Moore, Wisniewski, & Dobs, 2003). In turn, chronic disease and other health-related factors
may affect recommended hormone protocols or dosages. For example, more frequent and
lower testosterone doses are recommended for transmen with histories of trauma, as high or
frequent doses may cause emotional distress (Center of Excellence for Transgender Health,
2011).
Health and Mental Health Disparities
The transgender population also experiences a number of health disparities which
increases the need for access to appropriate routine and transition care. Although there is a lack
of population-level data on the health of the transgender population, existing evidence points to
both behavioral and mental health disparities. In particular, transgender young adults are more
likely to report heavy episodic drinking compared to non-trans young adults (Coulter et al.,
2015). Transmen and women also report a high prevalence of using alcohol and other drugs to
cope with experiences of stigma (Grant et al., 2011). The rate of smoking is also higher among
the transgender community than both lesbian, gay, or bisexual (LGB) individuals and the
general population (Shires & Jaffee, 2015b). Due to job discrimination and a resultant frequent
incidence of sex work, particularly among MTF, transgender individuals are at high risk for
HIV and other STIs. Depression is also common and the rate of suicidality and suicide attempts
among transgender persons are astronomically high (Grant et al., 2011; Kenagy, 2005). The
screening, diagnosis, and potential referrals that so often occur in primary care settings may be
crucial for transgender individuals who are smokers or have mental health or substance abuse
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issues. Likewise, as stated above, there is an established link between hormone use and mental
health status, so access to hormones may also contribute to alleviating mental health concerns
and risk behaviors (Colizzi et al., 2014; Keo-Meier et al., 2015; Wilson et al., 2015).
Healthcare Experiences Reported by Transgender Patients
An emerging body of literature suggests that transgender patients often have negative
experiences when seeking health care services, which may contribute to not being able to access
appropriate routine or transition care. One study recently found that 25% of transgender
participants in a survey in Virginia were not able to access needed trans-specific healthcare
services in the past 12 months. Of these, 31% of those could not access hormone therapy, 25%
could not access surgery, 25% could not access counseling, and 19% could not access
gynecological care (Bradford, Reisner, Honnold, & Xavier, 2013). Previous studies,
summarized below, have highlighted transgender patients’ perceptions that their providers
generally do not know how to appropriately treat them, documented incidents of harassment
and violence, and examined the prevalence of denial of care to this population.
Providers’ Lack of Knowledge
A number of qualitative studies have found that transgender patients report that their
physicians appear to be at a loss at how to provide care to them (Bauer et al., 2009; Poteat,
German, & Kerrigan, 2013a). Poteat and colleagues (2013a) found that transgender patients felt
that providers would not meet their needs or even be prepared to treat them at all. When
transgender patients have more information about their healthcare needs than the providers who
are treating them, the resulting shift in power can make providers quite uncomfortable and result
in substandard care for patients (Poteat et al., 2013a). Alternatively, a lack of knowledge on the
part of providers may directly result in care that is not ideal.
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More recent quantitative studies have confirmed these findings. Research using data
from the landmark National Transgender Discrimination Survey (Grant et al., 2011) suggest
that over half of transgender participants have to teach their healthcare providers about
transgender health issues (Jaffee, Shires, & Stroumsa, in press). In a sample of transgender
individuals in Virginia, 20% of the respondents reported having to educate their providers about
transgender health issues (Bradford et al., 2013). A recent study of transgender individuals in
Ontario, Canada found that many transgender patients (31% of transmen and 41% of
transwomen) reported that their primary care provider was not at all knowledgeable about
transgender issues (Bauer, Zong, Scheim, Hammond, & Thind, 2015). Collectively, these
studies indicate that having to teach a provider about transgender health is a relatively common
experience among transgender individuals seeking care.
Harassment and Discomfort
Numerous studies have documented experiences of bias against transpeople in
healthcare settings, and some transgender people even reported being physical assaulted when
seeking care (Grant et al., 2010; Shires & Jaffee, 2015a). Qualitative studies provide insights
into these experiences; transgender patients have reported being ridiculed or harassed by front
desk or pharmacy staff (Hussey, 2006), having their genitals or gender presentation be a focus
of the consultation even when irrelevant (Sperber, Landers, & Lawrence, 2005), and having
mental health issues blamed on their transgender identity (Bauer et al., 2009). They have also
reported having their provider refuse to use their preferred pronoun (Hussey, 2006; Sperber et
al., 2005), or feeling like their very existence as a transperson was being questioned (Bauer et
al., 2009; Poteat et al., 2013a).
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Denial of Care
Prior studies have also found that transgender individuals are often refused care outright.
In a 2005 needs assessment of transgender persons in Chicago, 12% had been refused routine
care and 23% had been refused transition-related care; 38% of respondents said that being
transgender created a problem for them related to seeking an annual physical (Kenagy &
Bostwick, 2005). A quarter of participants in the National Transgender Discrimination Survey
(NTDS) reported being refused care in a doctor’s office or hospital (Grant et al., 2011), although
whether participants were referring to routine care or transition care is unclear. In one study,
25% of transmen and 29% of transwomen had been told by a family or primary care physician
in the past that they don’t know enough about trans-related care to provide it, and 7% and 5%,
respectively, were denied care by a family physician because they are transgender (Bauer et al.,
2015). Qualitative studies have documented similar issues (Bauer et al., 2009; Poteat et al.,
2013a).
Implications of Reported Healthcare Experiences
Ultimately, negative experiences with physicians and other healthcare providers may
prevent transgender patients from seeking and obtaining needed routine and transition care. In
a Virginia study, only 43% of respondents reported being “out” to their primary care provider,
and 15% were uncomfortable or very uncomfortable discussing trans-specific healthcare needs
with their primary care provider (Bradford et al., 2013). Bauer and colleagues (2015) found that
when sociodemographic and trans-specific factors were controlled, prior negative experiences
and perceived lack of provider knowledge predicted discomfort with discussing trans-related
issues with a family physician. In addition, unadjusted analyses indicated that transgender
individuals who were planning to transition were more likely to report discomfort. Transgender
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participants in the NTDS who had to teach their providers about transgender health were four
times more likely than others to delay or avoid needed medical care (Jaffee, Shires, & Stroumsa,
in press). Finding appropriate healthcare can be an arduous task for many transgender persons
and may involve extensive research, travel, persistence, and finding insurance and policy
loopholes (Roller, Sedlak, & Draucker, 2015). In short, prior studies indicate that the barriers
reported by transgender individuals in need of care are nearly ubiquitous and extremely
daunting.
Provider-Level Factors Affecting Care Access for Transgender Patients
Although barriers to care from the perspective of transgender people have been
documented, less well understood is the perspective of healthcare providers and factors that
may contribute to difficulty in providing sensitive and high quality care to the transgender
population. This section reviews the available literature in this area, particularly as it pertains
to provider empathy, attitudes, subjective norms, exposure to transgender individuals, and
willingness to care for this population. Subsequently, gaps in the literature, both methodological
and content-related, will be described.
Exposure to Transgender Individuals
Studies of adolescent medicine and HIV providers indicate a fairly high level of
experience with transgender patients among this provider population. Among members of the
Society for Adolescent Health and Medicine and the Pediatric Endocrine Society, a majority
(67%) had provided clinical care to transgender youth; respondents had previously treated a
mean of 10.4 adolescent transgender patients each (Vance, Halpern-Felsher, & Rosenthal,
2015). Among HIV providers in New England, participants in a qualitative study reported
having a broad range of experience with transgender patients (Lurie, 2005). However, these
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providers likely do not represent primary care providers or clinicians generally, and no studies
to date have measured exposure to transgender patients among family medicine, internal
medicine, or ob-gyn providers in general.
Although the link between exposure to transgender individuals and willingness to
provide care to this population has not been studied, studies of clinicians’ attitudes towards
other vulnerable patient groups indicate a relationship between comfort or willingness to treat
and either personal or professional experience with this group. In a study of nursing students,
exposure (either personal or clinical) was positively correlated with comfort level in working
with patients of diverse races, gay, lesbian, or bisexual individuals, terminally ill patients, and
HIV positive patients, among others (Eliason & Raheim, 2000). Another study found that
exposure to gay and lesbian physicians and hearing their stories had an impact on decreasing
homophobia among medical students (Wallick, Cambre, & Townsend, 1995).
Empathy for Transgender Patients
Empathy, or the ability to understand another person’s feelings or point of view, is seen
as particularly important to the practice of medicine (Larson & Yao, 2005; Spiro, 2009). Prior
studies have linked physician empathy not only to patient satisfaction (Sullivan, Stein,
Savetsky, & Samet, 2000) but to clinical outcomes and factors that influence clinical outcomes,
including compliance (S. S. Kim, Kaplowitz, & Johnston, 2004). In one study, patients with
diabetes who perceive that their providers have greater levels of empathy had significantly
better clinical control of both their LDL cholesterol and hemoglobin A1C (Hojat et al., 2011).
Among medical students, empathy was positively associated with better core clinical skills
(Hojat, Gonnella, Mangione, et al., 2002). Although there is general agreement that empathy
can be taught, there is some evidence that female physicians have higher levels of empathy
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compared to male physicians, particularly in the area of “perspective taking” (Hojat, Gonnella,
Nasca, et al., 2002).
No studies to date have specifically examined the impact of provider empathy on
willingness to care for marginalized populations such as the transgender community, but at least
one qualitative study points to empathy as a potentially important factor: “Where providers sat
on the continuum between participation and resistance to transgender stigma/discrimination
seemed to be a function of empathy. Lesbian and gay providers as well as other providers who
felt a personal connection to transgender people were more likely to express resistance to
stigmatization of transgender people” (Poteat et al., 2013a, p. 27).
Perceived Knowledge about Transgender Health
One of the biggest barriers to treating transgender patients reported by healthcare
providers is feeling that they do not have the appropriate training or knowledge. Several prior
qualitative studies found that providers who serve transgender patients report feeling
uncomfortable or ambivalent about treating this population due to a lack of skills, training, and
information in this area (Lurie, 2005; Poteat, German, & Kerrigan, 2013b). Quantitative studies
report similar findings. Among a national sample of adolescent health care providers, most
participants (75%) were familiar with the Endocrine Society’s guidelines around transgender
medical therapy (Vance et al., 2015), but only 18% agreed that their training had adequate
emphasis on transgender care. Most had learned about caring for transgender youth after
medical school, and the majority wanted to learn more about caring for transgender youth (86%)
(Vance et al., 2015).
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Willingness to Provide Care
Based on reports of transgender patients, healthcare institutions generally have a long
way to go in order to ensure that care provided to the transgender community is sensitive and
culturally appropriate. The first step to alleviating these disparities, however, is to assess
whether providers are even willing to care for this population. Since transgender patients often
report being denied care, this is an extremely salient line of inquiry. Very few studies to date
have examined healthcare providers’ willingness to treat transgender patients. Unger (2015)
surveyed obstetrician-gynecologists in nine healthcare institutions across the United States,
with a resulting sample size of N=141. Providers were asked about both routine and transition
care services for transgender patients. In terms of routine care, a vast majority of respondents
(90%) reported being willing to provide routine pap smears for FTM patients who had not
undergone hysterectomy; 80% agreed that they would be willing to perform breast
examinations for MTF patients using estrogen. When asked about transition care, 65% were
willing to perform hysterectomies for FTM patients who had met the criteria for surgical
transition. Despite this willingness, only 29% and 34% of respondents reported that they were
comfortable caring for FTM and MTF patients, respectively. Although this study provides some
insight into willingness to care for transgender patients among obstetrician-gynecologists, it
does not address either other types of primary care providers or factors associated with
willingness to care for transgender patients.
Justification for the Current Study
There is increasing evidence that health outcomes for transgender patients are
suboptimal, and a lack of access to appropriate and sensitive care is a major barrier to improving
health among this population. It is critically important for transgender patients to receive both
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necessary routine care as well as desired transition care, and existing evidence suggests that
transgender patients are denied both routine and transition care on a regular basis. However,
little is known about what factors predict healthcare providers’ willingness to provide both
routine care and transition care to transgender patients. Barriers such as lack of knowledge or
training about transgender health clearly play a role, but it appears that motivated providers are
able to overcome such barriers (Vance et al., 2015).
In terms of transition care, primary care providers – such as internal medicine, family
medicine, and ob-gyn providers - are best positioned to either initiate or continue hormone
therapy for the transgender population. Prescribing hormones and monitoring hormonal
imbalances is well within the purview of primary care providers, for instance, in the case of
polycystic ovarian syndrome (Shannon & Wang, 2012) or hormone replacement related to
menopause (De Villiers et al., 2013). The only study assessing primary care providers’
willingness to treat transgender patients (Unger, 2015) did not assess willingness to provide
hormone treatment (either initiating or continuing hormone care). This question represents a
sizable gap in the literature, as the responsibility of managing gender-transition hormonal
regimens can and should fall to primary care providers (Wilczynski & Emanuele, 2014).
Whether a provider is willing to provide care to transmen and women or not is likely a
complex interplay between the providers’ personal characteristics, exposure to transgender
patients, empathy towards this population, attitudes regarding gender norms, and self-efficacy
around providing such care (including perceived knowledge). The results of this study may
point to potential improvements in medical and nursing education, healthcare organizations’
policies and procedures, or other target areas that will improve transgender health care.
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Identifying key factors related to providers’ willingness to care for this population is critical to
learn where to most effectively intervene to improve transgender healthcare.
Theoretical Framework
The theoretical framework for this study was primarily informed by the Theory of
Planned Behavior (Ajzen, 1991), but it was also influenced by Intergroup Contact Theory
(Pettigrew, 1998). The Theory of Planned Behavior, an adaptation of the Theory of Reasoned
Action (Madden, Ellen, & Ajzen, 1992), posits that three main factors influence behavioral
intentions, and thus, behaviors: attitudes toward the behavior, subjective norms related to the
behavior, and perceived behavioral control. The Theory of Planned Behavior (TPB) has
previously been used to predict the behavior of physicians and other healthcare providers. For
example, these constructs have successfully predicted whether physicians will deliver
counseling regarding the prevention of sexually transmitted infections to adolescent patients
(Millstein, 1996). The TPB has also been used to predict whether pharmacists will participate
in a drug monitoring program for their patients (Gavaza, Fleming, & Barner, 2014).
To date, the TPB has not been used to assess whether healthcare providers are willing
to treat a marginalized patient population such as the transgender community. Like the rest of
the population, healthcare providers are vulnerable to social biases and prejudice. Thus, it is
critical to account for potential bias, or factors that may mitigate bias, in the theoretical
framework for this study. Intergroup Contact Theory predicts that, through a number of
mechanisms, individuals who have contact with a member of an “out-group” will have more
positive attitudes towards that group (Pettigrew, 1998).
The modified TPB used in this study contains elements of both of these theories (as
illustrated in Figure 1). I predict that increased personal and clinical exposure to transgender
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individuals, fewer negative attitudes regarding non-binary gender norms (transphobia),
increased empathy towards transgender patients (empathetic attitudes), and greater self-efficacy
(fewer reported barriers and more reported facilitators) related to treating transgender patients
will predict providers’ increased willingness to provide routine care, continue HT, and initiate
HT for transgender patients.

Figure 1. Theoretical framework: Modified theory of planned behavior.
Study Aims
Given the range of barriers faced by transgender individuals when accessing healthcare
and known gaps in the literature related to healthcare providers’ willingness to provide routine
and transition care to transgender patients, the aims of this study are as follows:
4. To determine the association between provider characteristics, personal and
clinical exposure, transphobia, empathetic attitudes towards transgender patients,
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and transgender care-related self-efficacy on willingness to provide routine care to
transgender patients.
H1: When provider characteristics are controlled, increased personal and clinical
exposure, decreased transphobia, increased empathy attitudes, increased selfefficacy will be positively associated with willingness to provide routine care to
transgender individuals.
5. To determine the association between provider characteristics, personal and
clinical exposure, transphobia, empathetic attitudes towards transgender patients,
and transgender care-related self-efficacy on willingness to continue hormone
therapy for transgender patients.
H2: When provider characteristics are controlled, increased personal and clinical
exposure, decreased transphobia, increased empathetic attitudes, increased selfefficacy, and increased facilitators will be positively associated with willingness to
continue hormone therapy for transgender individuals.
6. To determine the association between provider characteristics, personal and
clinical exposure, transphobia, empathetic attitudes towards transgender patients,
and transgender care-related self-efficacy on willingness to initiate hormone
therapy for transgender patients.
H2: When provider characteristics are controlled, increased personal and clinical
exposure, decreased transphobia, increased empathy attitudes, and increased selfefficacy will be positively associated with willingness to initiate hormone therapy
for transgender individuals.
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CHAPTER 3: METHODOLOGY
This study is an analysis of de-identified survey data that were used to measure factors
associated with primary care providers’ willingness to treat transgender patients at Henry Ford
Health System. All study procedures and materials were approved by Henry Ford’s Institutional
Review Board. The study population, setting, participants, sampling, survey instrument,
analytical variables, and analysis, and data screening process are described below.
Study Population
Setting
Henry Ford Health System is an integrated care delivery system serving Detroit,
Michigan and its surrounding suburbs. The system owns a medical group of over 1,000 salaried
physicians and staffs 26 primary care clinics throughout metropolitan Detroit. The health
system has taken a number of steps to promote sensitivity to lesbian, gay, bisexual, and
transgender patients and employees. For example, the system added sexual orientation to its
employee and patient non-discrimination policies, though to date, gender identity has not been
included in system non-discrimination policies. Various diversity initiatives have begun to
address sexual orientation and gender identity in the health system, and the Health System was
designated as a LGBT healthcare equality leader in 2014 by the Human Rights Campaign. An
internal group has developed and piloted a LGBT sensitivity training for health system
providers and staff. Additionally, in the Fall 2015, the Human Resources department began
developing a plan to make the system more sensitive to transgender employees. However,
gender identity and sexual orientation information is not routinely collected from patients.
Despite strides in inclusivity, many improvements are still needed.
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Sampling
Eligible participants included all primary care (internal medicine and family medicine)
and women’s health providers practicing in the health systems’ affiliated medical group,
including attending physicians, advanced practitioners (physician assistants, nurse
practitioners, and certified nurse midwives), and medical residents. Health system and
departmental records were used to identify the study sample and to acquire each eligible
participant’s name, degree, specialty, and email address. In order to maximize sample size, the
universe of eligible participants was included in the sampling frame (N=389). The final sample
included 223 respondents, for an overall response rate of 57% (range = 45% to 100%,
depending on provider type and specialty). Table 1 describes the response rate overall, by
specialty, and by provider type.
Table 1
Provider Survey Response Rates

Provider specialty/type

Eligible
(n)

Respondent
(n)

Response rate
(%)

Internal medicine
Physicians
Advanced practitioners
Residents

97
5
117

44
3
66

45
60
56

Family medicine
Physicians
Advanced practitioners
Residents

64
1
24

32
1
17

50
100
71

Women’s health
Physicians
Advanced practitioners
Residents

43
23
15

30
19
11

70
83
73

Total

389

223

57
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Data Collection
Procedures
The survey was programmed into an online data collection tool. Study data were
collected and managed using REDCap (Research Electronic Data Capture) electronic data
capture tools hosted at Henry Ford Health System. REDCap is a secure, web-based application
designed to support data capture for research studies, providing 1) an intuitive interface for
validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3)
automated export procedures for seamless data downloads to common statistical packages; and
4) procedures for importing data from external sources (Harris et al., 2009). A unique link to
the survey was sent to each eligible participant in an email that contained informed consent
information, including an assurance of confidentiality and the voluntary nature of the survey,
along with information about the study incentives. Two follow-up emails were sent to nonrespondents. The survey took approximately 15 minutes to complete. Data were collected in
November and December of 2015; the survey link was emailed to eligible participants on
November 3, 2015. A reminder email was sent to remaining non-respondents on November 10,
2015, and a second reminder was sent to non-respondents on November 18, 2015. The online
survey was closed on December 18, 2015.
Incentives
Participants were each offered a $30 gift card to Target, a chain retail store. In addition,
participants were automatically entered into a random draw to be chosen to receive one of three
$100 Target gift cards. Incentives were mailed to participants within three weeks of survey
completion along with a letter thanking them for participating in the study that was signed by
the Principal Investigators (Deirdre Shires and Daphna Stroumsa).
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Measurement
Survey Instrument
The survey was developed in part based on adaptations of previously published survey
questions or previous studies whose authors were willing to share survey instruments; some
questions were developed specifically for this study. The relevant domains addressed in the
survey include provider demographics (constructed for this study), personal exposure to
transgender individuals (Berkman & Zinberg, 1997), clinical exposure to transgender patients
(construct for this study), willingness to care for transgender patients (Kelley, Chou, Dibble, &
Robertson, 2008; Unger, 2015), attitudes about gender norms (Nagoshi et al., 2008), and
provider empathy (Kiersma, Chen, Yehle, & Plake, 2013). The survey instrument is included
in Appendix A. Table 2 describes each of the theoretical constructs, corresponding survey
domains, and corresponding question numbers.
Control Variables
Provider characteristics included age, gender, specialty, provider type, gender,
race/ethnicity, religious identity, religiosity, and political views. Age was analyzed as a
continuous variable (i.e., age in years). Provider type included resident/fellow, advanced
practitioner, or attending physician. Specialty was categorized as internal medicine, family
medicine, general women’s health, or women’s health specialty. Gender was categorized as
male or female. Race/Ethnicity was categorized as African American, White, Asian or Pacific
Islander, or Other. Religion was categorized as Atheist/Agnostic, Christian, Muslim, Jewish,
Hindu, and Other. Religiosity was categorized as not religious, slightly religious, moderately
religious, and very religious. Political views were categorized as liberal, moderate, or
conservative.
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Table 2
Survey Domains Related to Theoretical Constructs

Study construct
Personal exposure

Domains/questions

Question
numbers

 Ever met transgender person
 Has transgender acquaintances/colleagues
 Hast transgender friends/family

13-15

Clinical exposure

 Cared for transgender patient in past 5 years
 Ever continued hormone therapy
 Ever initiated hormone therapy

17-19

Empathetic attitudes

 Empathy towards transgender patients

40-43

Transphobia

 Opinions regarding binary gender categories
and cultural gender norms

44-51

Self-efficacy

 Familiarity with routine care and transition
care protocols for trans patients
 Barriers to treating trans patients, related to
knowledge, insurance, staff, etc.

20; 25-26

Willingness

 Willingness to provide routine care
 Willingness to continue hormone therapy
 Willingness to initiate hormone therapy

32-38

21-24
27
28-29



Independent Variables
The construction of independent variables was driven by the Theory of Planned
Behavior and Intergroup Contact Theory (as described above) and included personal exposure,
clinical exposure, empathetic attitudes towards transgender individuals, transphobia, selfefficacy, and willingness to care for transgender patients. The variables included in each of
these domains are described below along with their sources, including three scales: transphobia,
empathy, and knowledge barriers. For each scale, exploratory factor analysis was conducted in
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order to examine factor structure. Cronbach’s alpha was also examined to determine whether
each scale demonstrated internal consistency.
Personal Exposure
Personal exposure was measured using three binary variables, ever met a transgender
person (constructed from 2 questions assessing whether the participant had met a female-tomale transgender person or met a male-to-female transgender person), transgender
acquaintances or colleagues, and transgender friends or family. Personal exposure questions
were constructed for this study but loosely based on a previously published study about social
workers’ attitudes towards gay and lesbian individuals (Berkman & Zinberg, 1997).
Clinical Exposure
Clinical exposure to transgender patients was characterized by three binary variables,
cared for transgender patient in past 5 years (yes/no); ever continued hormone therapy (HT) for
transgender patient (yes/no), and ever initiated HT for transgender patient (yes/no). Clinical
exposure questions were constructed for this study.
Empathetic Attitudes
A brief empathy scale was constructed to characterize attitudes towards transgender
patients. Due to space limitations, four questions were taken from a previously validated 15item empathy scale tested with healthcare providers, with permission from the original authors
(Kiersma et al., 2013). Two of the selected questions addressed cognitive empathy and two
questions addressed emotional empathy. The questions used a 7-point Likert scale, where
responses ranged from “strongly disagree” to “strongly agree”. One question (#41 on the
survey) was subsequently dropped due to a lack of correlation with the other three questions
and questionable face validity.
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To calculate the scale, the item answers were summed and a mean of the summed items
was calculated. Item means ranged from 5.4 – 6.2 (on a 7 point scale), indicating that on
average, participants somewhat agreed or agreed with empathy statements (higher scores
indicate higher levels of empathy). Factor loadings for the scale ranged from .431 - .849 on one
factor and Cronbach’s alpha was low (.320). However, the scaled variable was used due to the
consistent relationships between each of the 3 individual items and the outcome variables.
Transphobia
In order to measure transphobia, a previously published scale of attitudes regarding
gender non-conformity was used, with items measured on a 7-point Likert scale where answers
ranged from “strongly disagree” to “strongly agree” (Nagoshi et al., 2008). Eight of the nine
original questions were used for this study; question #1 from the original scale was dropped
due to lack of relevance to the current study. To calculate the scale, the item answers were
summed and a mean of the summed items was calculated. Higher scores indicated a greater
degree of transphobia. Exploratory factor analysis indicated that all 8 items loaded onto one
factor; factor loadings ranged from .510 - .814. Cronbach’s alpha for the resulting scale was
.846.
Self-efficacy
A scale (knowledge barriers) was constructed using four questions regarding
knowledge-related barriers to treating transgender patients due to the consistent relationship
between these variables and the study outcomes. Knowledge barriers included barriers related
to training on transgender health issues and familiarity with gender transition guidelines. Each
barrier where there was agreement (somewhat agree, agree, or strongly agree) constituted 1
point on the barriers scale (potential range = 0-4). This scale demonstrated good internal
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consistency (Cronbach’s alpha = .849), with item means ranging from .393 - .578. All four
items loaded onto one factor, with factor loadings ranging from .790 - .886.
Two other barriers were dichotomized, both related to administrative issues: don’t know
how to bill for services for transgender patients and lack of insurance reimbursement. Other
self-efficacy variables included feeling capable of providing routine care and being familiar
with any hormone regimen. These questions were adapted from another study with the author’s
permission (Unger, 2015).
Willingness
Three domains were measured here, including willingness to provide routine care,
willingness to continue HT, and willingness to initiate HT. These were measured on a 7-point
Likert scale with answers ranging from “strongly agree” to “strongly disagree”. Binary (yes/no)
outcome variables were constructed for each of these continuous variables, where participants
indicating that they “strongly agree”, “agree”, or “somewhat agree” were coded “yes”. All
others were coded “no”. Willingness questions were adapted from another study with the
author’s permission (Unger, 2015).
Data Screening
Data screening was conducted in order to 1) assess missing data patterns; 2) detect
potential collinearity among predictor variables; and 3) assess normality of data.
Missing Data
Each of the analytical study variables was examined for missing data. Table 3 below
indicates the level of missing data for each variable of interest. Each analytical variable was
complete for 90% or more of the study sample. Most variables had missing data for less than
five percent of respondents; only two variables (constructed scales) were missing for 5-10% of
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participants. Participants with missing data were excluded listwise for descriptive analyses and
pairwise for bivariate analyses. Only participants with full data for each variable of interest
were included in multivariate models.
Table 3
Frequency of Missing Data for Analytical Study Variables
Percent of participants with
missing responses

Variables

<1%

Age, sex, religion, religiosity, political views, ever met a
transgender person, have transgender acquaintance or
colleague, have transgender friends or family

1% to <5%

Sexual orientation, empathy scale, familiar with hormone
therapy regimen, insurance barrier, billing barrier, willing
to initiate hormone therapy, willing to provide routine care,
willing to continue hormone therapy

5% to <10%

Transphobia scale, knowledge barriers scale
Normality of Continuous and Ordinal Variables

Tests for normality were conducted for both ordinal and continuous variables.
Specifically, skewness and kurtosis were examined as well as histograms of each variable’s
distribution. The Kolmogorov-Smirnov Test for normality, which is appropriate for large
sample sizes, was also conducted for each ordinal and continuous variable (Mertler & Vannatta,
2002).
Table 4 describes the psychometric properties of each of the continuous and ordinal
study variables, including an assessment of the possible and actual range, the skewness and
kurtosis, and whether or not the Kolmogorov-Smirnov test for normality was statistically
significant. Overall, the only major indicator of non-normality was a significant Kolmogorov-
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Smirnov test for each study variable; however, this test is very sensitive and should generally
be interpreted in light of other measures of normality (Mertler & Vannatta, 2002). None of the
analytical variables were severely positively or negatively skewed (i.e., >1.00 or < -1.00)
(Mertler & Vannatta, 2002).
When individual variables are examined, age showed a slight positive skew, with a
number of participants clustered around the younger age range (i.e., 26-33 years old).
Transphobia scale results also showed a positive skew, indicating that participants cluster
around the lower end of the scale (i.e., less transphobia). Finally, empathy scale results were
somewhat negatively skewed, indicating that a number of participants reported higher levels of
empathy.
Table 4
Psychometric Properties of Continuous and Ordinal Study Variables

Variable

N

M (SD)

Age

222

Political views
Empathy scale
Transphobia scale
Knowledge
barriers scale

223
214
201
211

41.3
(13.6)
1.7 (0.7)
5.8 (0.9)
3.09 (1.1)
1.9 (1.6)

K-S Test
p value

Possible
range

Actual
range

—

26–72

.526

-1.204

<.001

1–3
1–7
1–7
0–4

1–3
3.3–7
1–7
0–4

.543
-.533
.628
.054

-1.015
-0.247
0.583
-1.606

<.001
<.001
.038
<.001

Skewness Kurtosis

Multicollinearity Assessment
Two steps were taken in order to detect potential collinearity among raw variables: 1) a
variance inflation factor (VIF) was calculated for all independent variables; and 2) Pearson’s r
tests were conducted for certain variables of interest. Pearson’s r carries assumptions of data
normality (Hauke & Kossowski, 2011), but each of the continuous and ordinal study variables
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exhibited signs of normality so Pearson’s r is an appropriate test (see Table 5). An analysis of
VIF for each independent variable showed no signs of multicollinearity; VIF ranged from 1.122
to 1.987, well within the normal range (1-10). Bivariate correlations were also assessed between
empathetic attitudes, transphobia, political views, and religiosity.
Table 5
Correlations Between Clinical and Personal Exposure Variables

Variables
Ever met transgender
person
Transgender Acquaintance
or colleague
Transgender Friends or
family
Transgender patient in past
5 years
Ever initiated HT
Ever continued HT

Ever
met

Acq or
Col

Friend
or Fam

Past 5
years

Initiate
HT

Contin
HT

—

.19

.05

.49

.08

.21

—

.30

.11

.02

-.05

—

.11

.12

.06

—

.15

.29

—

.21
—

Table 6
Correlations Between Self-efficacy Variables

Variables
Capable of providing
routine care
Familiar with HT
regimen
Insurance barrier
Billing barrier
Knowledge barriers
scale

Capable
Routine

Familiar
HT

Insurance
Barrier

Billing
Barrier

Know
Barriers

—

.16

.03

-.05

-.34

—

.16

.02

-.21

—

.32
—

.21
.30
—
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Table 7
Correlations Between Transphobia, Religiosity, Political Views, and Empathy

Variables

Transphobia

Transphobia
Religiosity
Political views
Empathy scale

—

Religiosity

Political
views

Empathy
Scale

.45
.30
—

-.46
-.10
-.24
—

.21
—

A number of significant correlations between study variables were detected. The highest
correlation between exposure variables was between ever met a transgender person and cared
for a transgender patient in the past 5 years (r=.49; Table 5). Among self-efficacy variables,
feeling capable of providing routine care and the knowledge barriers scale were the most highly
correlated (r= -.34; Table 6). Finally, the correlation between political views and transphobia
(.45) and the correlation between empathetic attitudes and transphobia (-.46) were also
relatively high (Table 7). However, no multicollinearity issues were detected, as correlations
among variables were all <.80.
Statistical Analysis
Univariate Analysis
Descriptive analyses were conducted for all study variables, including frequencies for
nominal measures and means and standard deviations for ordinal and continuous measures.
Bivariate Analysis
Chi square tests and t-tests for nominal and continuous variables, respectively, were
conducted to assess the relationship between each predictor variable and the dichotomous or
categorical study outcomes.
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Multivariate Analysis
Due to the nature of primary care practice (providers practicing within certain clinics or
sites), conducting multilevel analyses would be preferable. However, in order to perform
multilevel analyses such as HLM or the mixed model procedure in SPSS, an adequate number
of respondents per group is needed; one recommended benchmark is 30 respondents each
within 30 groups (Hofmann, 1997), although a greater number of groups can compensate for a
smaller number of respondents per group and vice versa. Because the total sample size is N=223
respondents nested within 24 sites, there is not enough power to conduct multilevel modeling.
In addition, medical residents and other providers practice in multiple sites, including providing
inpatient care, making nesting providers within sites extremely difficult.
Thus, binary logistic regression was chosen for the multivariate analysis in this study.
Three logistic regression models were examined, one to predict willingness to provide routine
care, one to predict willingness to continue HT, and one to predict willingness to initiate HT.
Variables were entered simultaneously.
A ratio of at least 10 events per predictor variable generally results in sufficient power
in logistic regression (Peduzzi, Concato, Kemper, Holford, & Feinstein, 1996). For the three
outcomes examined here, willingness to provide routine care had 171 “events”, willingness to
initiate HT had 48, and willingness to continue HT had 116, allowing a maximum of 17, 4, and
11 predictor variables in each of the three logistic regression models. Predictors were included
in the multivariate analysis for each outcome if bivariate relationships with the outcomes were
significant at the p<.10 level. For the model predicting willingness to initiate HT, an alpha level
of p<.05 was used due to the need to limit the number of predictor variables to four variables
in order to ensure that the event to predictor ratio was over 10.
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CHAPTER 4: RESULTS
The results of the study are described in this chapter, including the descriptive results,
bivariate associations, and multivariate analyses (three logistic regression models).
Descriptive Analyses
Provider Characteristics
Table 8 describes the primary care providers who participated in the study (N=223). In
terms of socio-demographic characteristics, study participants were on average 41.3 years of
age (SD=13.6). Over half of the respondents identified as female (59.5%) and White (56.1%).
One-fifth (20.4%) identified as Asian or Pacific Islander, and 7.7% listed their race as African
American or Black. Other participants described themselves as Southeast Asian or Asian Indian
(6.7%), and less than 5% of participants were identified as Arab American/Middle Eastern,
Hispanic, or other (data not shown). These categories were collapsed into an “other” category
(15.8%). The majority of the sample identified as heterosexual (95.9%).
In terms of religion, half of participants listed their religion as Christian (49.5%). Other
frequently designated religious affiliations included Muslim (17.1%), Hindu (12.2%), and
Agnostic or Atheist (8.1%). Most participants described themselves as either slightly,
moderately, or very religious (80.3%). Other participants identified as not religious at all (19.7).
About half of respondents indicated that they were politically liberal or very liberal (46.6%),
about one third were moderate or “middle of the road” (36.3%), and 17.0% defined themselves
as conservative or very conservative.
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Table 8
Provider Characteristics
Variable

N

%

Age (M, SD)

222

41.3 (13.6)

Gender
Male
Female

90
132

40.5
59.5

Race/ethnicity
White
African American/Black
Asian or Pacific Islander
Other

124
17
45
35

56.1
7.7
20.4
15.8

Sexual Orientation
Lesbian/Gay/Bisexual/Other
Heterosexual

8
210

4.2
95.9

Religion
Agnostic/Atheist
Christian
Jewish
Muslim
Hindu
Other

18
110
13
38
27
16

8.1
49.5
5.9
17.1
12.2
7.2

Religiosity
Not religious at all
Slightly religious
Moderate religious
Very religious

44
48
105
26

19.7
21.5
47.1
11.7

Political Views
Liberal
Moderate
Conservative

104
81
38

46.6
36.3
17.0

Specialty
Internal Medicine/Family Medicine
General Women’s Health (Ob/Gyn)
Women’s Health Specialty

163
47
13

73.1
21.1
5.8

Provider Type
Resident
Advanced Practitioner
Attending Physician

94
23
106

42.2
10.3
47.5

Note. N = 223.
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Provider Type and Specialty
Most respondents were either internal medicine or family medicine providers (73.1%)
(Table 8). The rest of the participants were either general women’s health (ob/gyn) providers
(21.1%) or women’s health specialty providers (5.8%) – for example, urogynecologists or
reproductive endocrinologists. About half the sample was comprised of attending physicians
(47.5%) and 42.2% of respondents were medical residents. The other 10.3% of respondents
were advanced practitioners (physician assistants, nurse practitioners, or nurse midwives).
Independent Variables
Personal and clinical exposure to transgender individuals, empathetic attitudes,
transphobia, barriers/facilitators, and willingness to treat transgender patients are described in
Table 9. The results are discussed below.
Exposure to Transgender Individuals
Exposure to transgender individuals included two domains: personal exposure and
clinical exposure. Most participants had previously met a transgender person (77.9%).
Although only 4.1% of respondents had transgender family members or friends, 14.9%
indicated that they had transgender acquaintances or colleagues. Approximately half of
participants indicated that they had cared for a transgender patient in the past five years, but
only 2.2% had ever initiated hormone therapy and 13.6% had ever continued a hormone therapy
regimen initiated by another healthcare provider.
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Table 9
Personal and Clinical Exposure, Empathetic Attitudes, Transphobia, Self-efficacy, and
Willingness to Care for Transgender Patients
Variable
Personal Exposure
Ever met a transgender person
Has transgender acquaintances or colleagues
Has transgender family or friends
Clinical Exposure
Ever initiated hormone therapy regimen
Ever continued hormone therapy regimen
Cared for transgender patient in past 5 years
Empathetic Attitudes Score (mean, SD)
Transphobia Score (mean, SD)
Self-efficacy
Don’t know how to bill for services
Lack of insurance reimbursement
Knowledge barriers scale (mean, SD)
Capable of providing routine care
Familiar with any hormone regimen (FTM or MTF)
Willingness
Willingness to provide routine care
Willingness to initiate hormone therapy
Willingness to continue hormone therapy
Note. N = 223.

n

%

173
33
9

77.9
14.9
4.1

5
30
111
214
201

2.2
13.6
50.2
5.8 (0.9)
3.1 (1.1)

20
7
211
138
28

9.3
3.3
1.9 (1.6)
62.4
12.7

171
48
116

77.7
22.1
53.2
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Empathetic Attitudes
Three empathy variables (measured on a 1-7 Likert scale, where 7 = “strongly agree”)
were summed in order to create a scale. The mean for the summed items, “it is necessary for a
healthcare provider to comprehend others’ experiences”, “I am able to value someone else’s
point of view”, and “Considering a patient’s feelings is not necessary for patient-centered care”
(reverse-coded) was 5.8 (SD = 0.9), indicating that on average, participants somewhat agreed
or agreed with the empathy statements.
Transphobia
The mean transphobia score for participants was 3.1 (Range = 1-7; SD = 1.1). A score
of 3 (somewhat disagree) indicates that on average, participants had moderately low levels of
transphobia.
Trangender Care-Related Self-efficacy
The most frequently cited barriers to treating transgender patients were related to a lack
of familiarity with transition care guidelines (57.0%), a lack of training in transgender-specific
care (54.3%), a lack of exposure to transgender patients (38.1%), and a lack of knowledge about
transgender patients among nursing or support staff (33.2%) (individual variables not shown).
These items were used to construct a knowledge barriers scale - a count of the number of
knowledge or exposure-related barriers that each participant faced (range = 0-4). The
knowledge barriers scale mean was 1.9 (SD = 1.6) or nearly 2 knowledge barriers per
participant (Table 9). Fewer participants indicated that they had administrative barriers, such as
not knowing how to bill for transgender-specific services (9.3%) or that there is a lack of
insurance reimbursement for transgender care (3.3%).
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Fewer than two-thirds of providers (62.4%) reported feeling capable of providing
routine care to transgender patients; only 12.7% were familiar with any gender transition
hormone regimen (for either male-to-female transgender patients, female-to-male transgender
patients, or both).
Willingness to Provide Care
Participants indicated whether they were willing to provide routine care, continue
hormone therapy initiated by another provider, or initiate hormone therapy for transgender
patients. The majority of participants agreed (strongly agreed, agreed, or somewhat agreed) that
they were willing to provide routine care to male-to-female transgender patients (81.6%) as
well as female-to-male transgender patients (81.2%) (data not shown). Most participants were
willing to provide routine care to both FTM and MTF patients (77.7%). About half of survey
respondents agreed (strongly agreed, agreed, or somewhat agreed) that they were willing to
continue a hormone therapy regimen that was initiated by another healthcare provider (53.2%).
Among survey respondents, 22.0% were willing to initiate a hormone therapy regimen for maleto-female transgender patients and 22.9% were willing to initiate hormone therapy for femaleto-male patients (data not shown). About one-fifth (22.1%) of health providers surveyed were
willing to initiate hormone therapy for both FTM and MTF patients.
Bivariate Associations
The following section describes the results of chi square tests and t-tests to test
associations between independent variables and the study outcomes: willingness to provide
routine care, willingness to continue a hormone therapy regimen, and willingness to initiate a
hormone therapy regimen. The alpha level for bivariate associations was set at .10, which is
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considered appropriate for studies with limited sample sizes and under circumstances where
making a Type I error would not have severe consequences (Stevens, 2012).
Factors Associated with Willingness to Provide Routine Care
Provider type and specialty. Provider type and clinical specialty were associated with
willingness to provide routine care, with internal medicine and family medicine providers more
likely to be willing to provide routine care to transgender patients compared to general women’s
health or specialty women’s health providers (85% vs. 63.8% and 76.9%, respectively).
Medical residents (89.1%) were more likely than advanced practitioners to be willing to provide
routine care (69.6 and 74.3%, p=.014).
Provider characteristics. Age was associated with willingness to provide routine care;
participants who were willing were younger on average (mean=40.2 years, SD = 13.7)
compared to participants who were not willing to provide routine care (mean = 45.4 years, SD
= 12.5) (Table 7). Political views were also associated with willingness to provide routine care,
with more liberal participants being more likely to be willing (p=.088) (Table 5). However,
gender, race, sexual orientation, religion, and religiosity were not associated with willingness
to provide routine care to transgender patients.
Exposure. Participants who had met a transgender person where more likely to
indicate a willingness to provide routine care (84.2% vs. 66.7%, p=.007) (Table 6). In terms
of clinical experience, providers who had cared for at least one transgender patient in the past
five years were more likely to be willing to provide routine care to this population (p=.007).
Transphobia and Empathetic Attitudes. Providers who were willing to provide
routine care to transgender patients had higher empathy scores (mean = 5.9 vs. mean = 5.4)
and lower transphobia scores (mean = 3.0 vs. mean = 3.5).
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Self-efficacy. Those who reported that they felt capable of providing routine care to
transgender patients (93.1% vs. 56.6%, p<.001) and reported fewer knowledge barriers (mean
= 1.7 vs. mean = 2.5) were more willing to provide routine care to this population (Table 7).
Those who reported that they did not know how to bill for services provided to transgender
patients were less likely to be willing to provide routine care (60.0% vs. 81.9%, p=.020)
(Table 6).
Factors Associated with Willingness to Continue a Hormone Therapy Regimen
Provider Type and Specialty. Residents were more likely to be willing to continue a
hormone therapy regimen (63.0%) compared to advanced practitioners (47.8%) and attending
physicians (45.6%, p=.045). There were no significant differences among specialties (Table
5).
Provider Characteristics. Provider characteristics that were associated with
willingness to continue a hormone therapy regimen included race/ethnicity (p=.010) and
religion (p=.021)(Table 5). White respondents (61.8%) and Jewish respondents (84.6%) were
most willing. Gender, sexual orientation, religiosity, and political views were not associated
with willingness to continue a hormone therapy regimen (Table 5).
Exposure. Providers who had met a transgender person before were more likely to be
willing to continue a hormone therapy regimen compared to those who had not (58.0% vs.
35.4%, p=.006) (Table 6). Those who had initiated a hormone therapy regimen for a
transgender patients in the past were also more likely to be willing to continue HT in the
future (p=.034). Participants who had ever continued a hormone therapy regimen before were
also more likely compared to participants who had not continued HT for a transgender patient
in the past (79.3% vs. 49.2%, p=.010). In addition, those who cared for a transgender patient
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in the past 5 years were more willing to continue a hormone therapy regimen as well
(p=.076).
Transphobia and Empathetic Attitudes. Both empathetic attitudes towards
transgender patients and transphobia scale scores were significantly associated with
providers’ willingness to continue a hormone therapy regimen (Table 8). Higher empathetic
attitudes scores were found among participants who were willing to continue a hormone
therapy regimen (mean=5.8, SD = 0.8) compared to those who were not willing (mean = 5.7,
SD = 1.0, p=.095). Those who were willing had comparatively lower transphobia scores
(mean = 2.9, SD = 1.0) compared to those who were not willing (mean = 3.3, SD = 1.1).
Self-efficacy. Those who reported being capable of providing routine care were more
likely to be willing to continue hormones compared to those who did not agree that they were
capable (58.5% vs. 43.9%, p=.036). Finally, providers who reported being familiar with a
hormone therapy regimen for either FTM or MTF transgender patients were more likely to be
willing (81.5% vs. 49.2%, p=.002).
Factors Associated with Willingness to Initiate a Hormone Therapy Regimen
Provider Type. Medical residents were more likely to be willing to initiate hormone
therapy for transgender patients (35.9%) compared to advanced practitioners and attending
physicians (p<.001), but there were no differences by specialty.
Provider Characteristics. Two provider characteristics were associated with
willingness to initiate a hormone therapy regimen: age and political views. Providers who
were willing to initiate hormones were younger than those who were not (mean = 34.7 years,
SD = 11.3 vs. mean = 43.1 years, SD = 13.7, p<.001)(see Table 9). Conservative or very
conservative participants were less likely to be willing to initiate hormone therapy (8.3%)
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compared to those who described themselves as moderate (26.3%) or liberal (23.8%) (Table
6). Gender, race, sexual orientation, religion, and religiosity were not associated with
willingness to initiate HT.
Exposure. Exposure variables were not significantly associated with willingness to
initiate HT.
Transphobia and Empathetic Attitudes. Transphobia and empathetic attitudes were
not significantly associated with willingness to initiate HT.
Self-efficacy. Participants who indicated that insurance reimbursement was a barrier
were also more likely to be willing (57.1% vs. 21.2%, p=.025). Finally, those who reported
being familiar with hormone regimens for FTM or MTF patients were more likely to be
willing to initiate hormone therapy for these patients (37.0% vs. 20.0%, p=.046).
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Table 10
Chi Square Tests of Willingness to Provide Routine Care, Continue Hormone Therapy, and
Initiate Hormone Therapy by Provider Characteristics

Variable

Routine
Care
%

Gender
Male
Female

80.7
79.4

Race/ethnicity
White
African American/Black
Asian or Pacific Islander
Other

77.7
94.1
75.6
80.0

Sexual Orientation
Lesbian/Gay/Bisexual/Other
Heterosexual

100.0
79.3

Religion
Agnostic/Atheist
Christian
Jewish
Muslim
Hindu
Other

100.0
80.7
61.5
75.7
77.8
87.5

Religiosity
Not religious at all
Slightly religious
Moderately religious
Very religious

90.7
68.8
78.6
73.1

Political Views
Liberal
Moderate
Conservative

84.5
80.0
67.6

Specialty
Internal/Family Medicine
General Women’s Health
Women’s Health Specialty

85.0
63.8
76.9

Provider Type
Resident
Advanced Practitioner
Attending Physician

89.1
69.6
74.3

Note. N = 223.

p

Continue
HT
%

.815

p

Initiate
HT
%

.891
54.0
53.1

.288

.578
24.1
20.9

.010
61.8
52.9
32.6
48.5

.151

.579
18.9
29.4
27.3
21.9

.567
62.5
53.2

.144

.511
37.5
22.1

.021
55.6
57.9
84.6
47.2
29.6
43.8

.143

.802
22.2
19.8
15.4
27.8
18.5
31.3

.894
56.8
51.1
53.9
48.0

.088

.496
27.9
23.4
21.6
12.0

.459
53.4
57.0
44.4

.006

.085
23.8
26.3
8.3

.364
50.3
61.7
58.3

.014

.355
20.1
29.8
18.2

.045
63.0
47.8
45.6

p

<.001
35.9
17.4
10.8
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Table 11
Chi Square Tests of Willingness to Provide Routine Care, Continue Hormone Therapy, and
Initiate Hormone Therapy by Exposure, Empathy, Transphobia/Subjective Norms, and SelfEfficacy
Routine
Care
%

Variable

p

Cont.
HT
%

p

Initiate
HT
%

p

Personal Exposure
Ever met a transperson
Yes
No

84.2
66.7

.007

Transgender acquaintances or colleagues
Yes
No

90.6
78.5

Transgender family or friends
Yes
No

77.8
80.5

.006
58.0
35.4

.162

.567
23.1
19.1

.164
63.6
50.8

.131

.570
25.0
21.3

.452
66.7
52.4

.135
50.0
21.2

Clinical Exposure
Ever initiated hormone therapy regimen
Yes
No

80.0
80.0

1.00

Ever continued hormone therapy regimen
Yes
No

80.0
79.8

Cared for transgender patient in past 5 yrs
Yes
No

85.5
70.4

.034
100.0
52.1

.777

.889
25.0
22.1

.010
79.3
49.2

.007

.461
27.6
21.0

.076
59.3
47.2

.263
25.0
18.7

Self-efficacy
Capable of providing routine care
Yes
No

94.1
56.6

Familiar with any hormone regimen (FTM or MTF)
Yes
No

78.6
77.4

Don’t know how to bill for services
Yes
No
Lack of insurance reimbursement
Yes
No

Note. N = 223.

<.001

.036
58.5
43.9

.887

.002
81.5
49.2

.020
60.0
81.9

.046
37.0
20.0

.463
45.0
53.6

.539
71.4
80.8

.485
23.3
19.3

.401
30.0
21.8

.827
57.1
52.9

.025
57.1
21.2

45
Table 12
t-Tests of Association between Continuous Predictor Variables and Willingness to Provide
Routine Care
Willingness to Provide Routine Care
Variable
Age
Empathy scale
Transphobia scale
Knowledge barriers scale

Yes
M (SD)

No
M (SD)

T

df

p

40.2 (13.7)
5.9 (0.8)
3.0 (1.1)
1.7 (1.6)

45.4 (12.5)
5.4 (0.9)
3.5 (1.1)
2.5 (1.6)

-2.4
3.3
-3.1
-2.8

217
210
197
207

.018
.001
.002
.005

Table 13
t-Tests of Association between Continuous Predictor Variables and Willingness to Continue
Hormone Therapy
Willingness to Continue Hormone Therapy
Variable
Age
Empathy Scale
Transphobia Scale
Knowledge Barriers Scale

Yes
M (SD)

No
M (SD)

T

df

p

40.5 (14.0)
5.8 (0.8)
2.9 (1.0)
1.8 (1.6)

42.2 (13.2)
5.7 (1.0)
3.3 (1.1)
1.9 (1.6)

-0.9
1.7
-3.0
-0.4

215
211
198
208

.377
.095
.003
.722

Table 14
t-Tests of Association between Continuous Predictor Variables and Willingness to Initiate
Hormone Therapy
Willingness to Initiate Hormone Therapy
Variable
Age
Empathy Scale
Transphobia Scale
Knowledge Barriers Scale

Yes
M (SD)

No
M (SD)

t

df

34.7 (11.3)
5.8 (0.9)
2.9 (1.1)
1.7 (1.7)

43.1 (13.7)
5.7 (0.9)
3.2 (1.1)
1.9 (1.6)

-4.3
0.5
-1.4
-0.9

214
210
198
207

p
<.001
.649
.159
.392
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Multivariate Results
Three binary logistic regression models were examined in order to simultaneously
consider factors that predict willingness to provide routine care (Model 1), willingness to
continue a hormone therapy regimen (Model 2), and willingness to initiate a hormone therapy
regimen (Model 3). Control and predictor variables that were significantly associated with the
outcomes in the bivariate analyses at the p<.10 level were included in the multivariate models,
with the exception of Model 3, which used an alpha level of p<.05 in order to limit the number
of predictor variables in the model due to sample size and power limitations (Peduzzi et al.,
1996). However, including only variables significant at the p<.05 level can fail to identify
important associations (Bursac, Gauss, Williams, & Hosmer, 2008). In addition, the alpha level
for reporting logistic regression results was set at .10 due to the relatively small sample size
(Stevens, 2012).

Model 1: Willingness to Provide Routine Care
Variables entered into the logistic regression model to predict willingness to provide
routine care included age, political views, provider specialty, provider type, ever met a
transgender person, cared for transgender patients in the past 5 years, empathetic attitudes,
transphobia, capable of providing routine care, billing barriers, and knowledge barriers (Table
15). The overall model was significant, χ2(14, N=187) = 75.16, p<.001, Cox & Snell pseudo R2
= .331.
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Table 15
Logistic Regression Analyses of Factors that Predict Providers’ Willingness to Provide
Routine Care to Transgender Patients
Variable

AOR

95% CI

p

Age

0.99

0.94–1.04

.712

Political Views
Liberal (ref)
Moderate
Conservative

1.00
0.69
0.73

0.23–2.09
0.17–3.22

.507
.678

Specialty
Internal/Family Medicine (ref)
General Ob/gyn
Specialty Ob/gyn

1.00
0.20
0.39

0.06–0.71
0.04–3.53

.013
.400

Provider Type
Resident (ref)
Advanced Practitioner
Attending Physician

1.00
0.35
0.18

0.04–2.79
0.04–0.81

.320
.025

Ever met transgender person

3.23

0.82–12.66

.093

Transgender patients in past 5 years

1.04

0.32–3.39

.947

Empathy

1.62

0.88–2.97

.121

Transphobia

0.70

0.40–1.23

.213

13.22

4.45–39.31

<.001

Billing barriers

0.48

0.09–2.46

.375

Knowledge barrier scale

1.18

0.83–1.67

.363

Capable of providing routine care to
transgender patients

Note. N = 187.
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Four variables significantly contributed to the model – provider specialty, provider type,
ever met a transgender person, and capable of providing routine care. Compared to
internal/family medicine physicians, general ob/gyn providers were less likely to be willing to
provide routine care (AOR = 0.20, p=.013). Attending physicians were less likely to be willing
to provider routine care to transgender patients compared to medical residents (AOR = 0.18,
p=.025). Participants who had met a transgender person in the past were over three times more
likely to be willing to provide routine care when other factors were controlled (AOR = 3.23,
p=.093). Providers who reported that they felt capable of providing routine care were 13 times
more likely to be willing to provide such care compared to others (AOR = 13.22, p<.001).
Model 2: Willingness to Continue a Hormone Therapy Regimen
The variables race, religion, provider type, ever met a transgender person, cared for
transgender patients in the past 5 years, ever continued hormone therapy, transphobia,
empathetic attitudes, capable of providing routine care, and familiar with any hormone therapy
regimen were entered into a logistic regression model to predict willingness to continue a
hormone therapy regimen initiated by another healthcare provider (Table 16). The model was
significant, χ2(17, N=192) = 59.923, p<.001, Cox & Snell pseudo R2 = .268.
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Table 16
Logistic Regression Analyses of Factors that Predict Providers’ Willingness to Continue a
Hormone Therapy Regimen Initiated by Another Provider
Variable

AOR

95% CI

p

Race
Black (ref)
Asian or Pacific Islander
White
Other

1.00
0.55
1.13
0.95

0.10–2.86
0.29–4.37
0.19–4.75

.475
.860
.950

Religion
Agnostic/Atheist (ref)
Christian
Jewish
Muslim
Hindu
Other

1.00
3.25
19.24
1.86
1.13
1.25

0.89–11.86
2.48–149.58
0.38–9.06
0.20–6.53
0.24–6.92

.075
.005
.443
.892
.803

Provider Type
Resident (ref)
Advanced Practitioner
Attending Physician

1.00
0.19
0.26

0.55–0.66
0.12–0.58

.009
.001

Ever met transgender person

2.95

1.11–7.83

.030

Transgender patients in past 5 years

0.62

0.27–1.41

.252

Ever continued hormone therapy

5.06

1.49–17.24

.010

Transphobia scale

0.71

0.48–1.05

.083

Empathetic Attitudes

1.18

0.75–1.87

.470

Capable of providing routine care to
transgender patients

1.80

0.87–3.72

.112

Familiar with any hormone therapy
regimen (for FTM or MTF)

2.92

0.89–9.57

.077

Note. N = 192.
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Variables that significantly contributed to the model included religion, provider type,
ever met a transgender person, ever continued hormone therapy, transphobia, and familiar with
any hormone therapy regimen. Jewish providers were 19 times more likely to be willing to
continue a hormone therapy regimen compared to agnostic or atheist providers (AOR = 19.24,
p=.005), and Christian providers were also more likely (AOR = 3.25, p=.075). Advanced
practitioners (AOR = 0.19, p=.009) and attending physicians (AOR = 0.26, p=.001) were less
likely to be willing to continue hormones compared to residents. Those who had ever met a
transgender person had greater odds of being willing to continue HT compared to those who
had not (AOR = 2.95, p=.030). Participants who had ever continued a hormone therapy regimen
for a transgender patient in the past were more likely to be willing to do so in the future (AOR
= 5.06, p=.010), and those who were familiar with any HT regimen were also more willing
(AOR = 2.92, p=.077). Finally, increased transphobia was associated with decreased likelihood
of being willing to continue hormone therapy (AOR = 0.71 p=.083).
Model 3: Willingness to Initiate a Hormone Therapy Regimen
In the third logistic regression model, variables that had a significant bivariate
association with willingness to initiate a hormone therapy regimen for transgender patients
included age, provider type, familiar with any hormone regimen, and insurance barriers (Table
17). The model was significant, χ2(5, N=209) = 30.021, p<.001, Cox & Snell pseudo R2 = .134.
Three variables significantly contributed to the model: provider type, familiar with any
hormone therapy regimen, and insurance barriers. Attending physicians had lower odds of being
willing to initiate HT compared to residents (AOR = 0.31, p=.063). In addition, providers who
were familiar with the hormone therapy regimen for FTM or MTF patients were nearly 3 times
more likely to be willing to initiate this type of care compared to others (AOR=2.65, p=.059).
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Finally, reporting insurance barriers increased the odds of being willing to treat transgender
patients (AOR= 4.85, p=.089).
Table 17
Logistic Regression Analyses of Factors that Predict Providers’ Willingness to Initiate a
Hormone Therapy Regimen for Transgender Patients
Variable

AOR

95% CI

p

Age

0.97

0.93–1.02

.271

Provider Type
Resident (ref)
Advanced Practitioner
Attending Physician

1.00
0.47
0.31

0.93–2.33
0.09–1.07

.353
.063

Familiar with any hormone therapy regimen
(for FTM or MTF)

2.75

0.90–8.40

.075

Barrier: Insurance

4.85

0.79–29.82

.089

Note. N = 209.
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CHAPTER 5: DISCUSSION
This is the first study to assess primary care providers’ willingness to deliver both
routine and transition care to transgender patients. The majority of providers surveyed in this
study were willing to provide routine or basic care to transgender individuals; about half were
willing to continue HT for transgender patients, and a minority (22%) were willing to initiate
HT. This chapter discusses factors associated with willingness to provide each of these three
types of care, the relationship of the findings to the Theory of Planned Behavior and Intergroup
Contact Theory, implications for health care and social work, limitations, and directions for
future research.
Willingness to Provide Routine Care
Routine care includes services such as chronic disease management, acute care for
illnesses like influenza, pelvic examinations, and preventive care. Nearly one quarter of primary
care providers surveyed were not willing to provide such basic care to transgender patients.
This likely has a direct impact on access to care or perceived access to routine care this
community. Although somewhat dated, one review found that only 30-40% of transgender
individuals receive routine medical care (Feldman & Bockting, 2003). In contrast,
approximately 80% of the general population reported having a regular source of care around
the same time period (Beal, Doty, Hernandez, Shea, & Davis, 2007).
Previously,

Unger

and

colleagues

found

that

among

a

sample

of

obstetrician/gynecologists from 9 different health systems, 88.7% were willing to perform
routine pap smears for female-to-male patients and 80.4% were willing to perform breast
examinations for male-to-female patients taking hormones or who had breast augmentation
(2015). In this study, general women’s health providers and women’s health specialists were
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willing to deliver routine care at lower rates of 63.8% and 76.9%, respectively. Although the
difference in rates of willingness between this study and Unger’s study may be due to variation
in measurement, the current study used incentives and had a somewhat higher response rate,
possibly resulting in a more representative sample. Alternatively, providers in the Midwestern
U.S. may be less willing to care for transgender patients compared to women’s health providers
in other regions, as Unger’s study surveyed providers from multiple sites across the United
States.
Provider respondents who had met a transgender person before were over three times
more likely to be willing to provide routine care to them. The relationship between personal
exposure to transgender individuals and willingness to care for them has not been explored
before. However, one previous study found that nursing students who had personal experience
with lesbian, gay, or bisexual people were more comfortable providing care to LGB patients
(Eliason & Raheim, 2000).
Furthermore, there was a significant bivariate relationship between having cared for a
transgender patient in the past 5 years and willingness to provide routine care for this
population. Previous studies have similarly found associations between clinical exposure to
LGBT patients and attitudes regarding, or comfort working with, LGBT patients (Baylor &
McDaniel, 1996; Eliason & Raheim, 2000). However, clinical exposure variables did not make
a significant contribution to the multivariate model predicting willingness to deliver routine
care in this study.
Finally, those participants who reported feeling capable of providing routine care to
transgender patients were over 13 times more likely to be willing to provide such care. Previous
qualitative studies have found that providers report feeling uncomfortable caring for
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transgender patients due to a lack skills or training (Lurie, 2005; Poteat et al., 2013b). It may
be that knowledge-related barriers explain the relationship between feelings of capability and
willingness to deliver basic care to transgender patients. Post hoc analyses revealed that the
relationship between knowledge-related barriers and feelings of capability was significant
(participants who felt capable reported fewer barriers on average), but providers who report
feeling capable did report a mean of 1.7 knowledge barriers. Therefore, knowledge does not
completely explain the relationship between capability and willingness.
Willingness to Continue Hormone Therapy
Many transgender individuals are interested in pursuing hormone therapy as part of their
transition process, and this simple step can have profound psychological benefits (Keo-Meier
et al., 2015). Although endocrinologists are often part of an initial care team and initially
prescribe hormone treatment, there is general agreement that primary care providers can
continue HT and monitor its effects (Wilczynski & Emanuele, 2014), even among
endocrinologists (Gardner & Safer, 2013). PCPs often initiate and monitor hormone therapy for
a number of other purposes. However, only half of primary care providers surveyed in this study
were willing to continue HT for participants who had been started on HT by another provider.
Both personal and clinical factors contributed to providers’ willingness to continue HT.
Similarly to routine care, those who had met a transgender person were more likely to be willing
to continue HT. In addition, participants with lower levels of transphobia were more willing.
These findings indicate that even when clinical experience is accounted for, personal values or
attitudes still play a role in determining which providers are willing to assist transgender
patients in transitioning to the gender with which they identify. Past studies have clearly
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indicated that healthcare providers’ values and biases play a role in dictating their behavior and
that physicians are often not even aware of their biases (Chapman, Kaatz, & Carnes, 2013).
However, clinical specialty and experiences are also important; advanced practitioners
and attending physicians were less willing to provide HT compared to medical residents. In
addition, those who had participated in this kind of care before and those who reported being
familiar with HT regimens for transitioning were more likely to be willing to continue HT for
patients. Increasing familiarity with transition-related HT may be as simple as incorporating
this topic into training programs; one recent study found that adding just a one-hour lecture on
transgender health and hormone treatment significantly increased medical students’ comfort
and willingness to treat transgender patients (Safer & Pearce, 2013).
Willingness to Initiate Hormone Therapy
Although endocrinologists have generally been tasked with initiating new HT regimens
for transgender patients, initiating HT is considered straightforward and appropriate for primary
care physicians to initiate as well (Gardner & Safer, 2013). Medical transition guidelines have
evolved and are moving towards an informed consent model, where primary care physicians
may be responsible for both identifying gender dyphoria issues and initiating a patient’s
transition process (Wilczynski & Emanuele, 2014). Furthermore, access to transition care,
particularly in non-urban areas where specialists may not be available, necessitates the
involvement of primary care providers in initiating HT. However, very few respondents in this
study (22%) were willing to initiate hormone therapy for transgender patients.
Similarly to factors predicting willingness to continue HT, attending physicians were
less likely to be willing to initiate HT compared to residents. Familiarity with HT regimens also
increased the odds of willingness. However, those who reported insurance-related barriers to
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treating transgender patients were nearly 5 times more willing to initiate HT. This may be
because providers unwilling to deliver such care may not even realize that insurance-related
barriers exist.
Increasing primary care providers’ willingness to initiate and continue HT could greatly
expand access to this service for a population that faces numerous barriers to transition care.
For instance, improving access to HT through primary care may reduce unsafe behaviors such
as self-medication with hormones procured through non-medical avenues (Xavier et al., 2013).
Being able to access HT in primary care settings may have other benefits as well. Transgender
patients who receive HT from endocrinologists may not access primary care, thus missing out
on preventive care, cancer screenings, chronic disease management, and other important routine
care services – including smoking cessation counseling and mental health screening. The
benefits of receiving primary care have been well documented (Starfield, Shi, & Macinko,
2005). If primary care physicians are willing to both initiate and continue HT, transgender
patients will be more likely receive comprehensive health care services, which is particularly
important given the health and mental health disparities that this population experiences
(Coulter et al., 2015; Grant et al., 2010; Shires & Jaffee, 2015b).
Furthermore, recent improvements in healthcare delivery include an increasing focus on
establishing medical homes. Patients who have a medical home, by definition, have a regular
doctor or provider, can reach their provider by phone, are able to get either healthcare services
or medical advice in the evening or on the weekends, and have access to timely, organized care
(Beal et al., 2007). Access to a medical home has been shown to decrease and almost eliminate
racial disparities related to care access and quality (Beal et al., 2007). Access to a patientcentered, culturally competent medical home may have similar benefits for other underserved
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populations, including the transgender community. It may be that transgender individuals who
are able to get transition care in a primary care setting may be more likely to seek out and
continue to access a medical home.
Theoretical Framework: Theory of Planned Behavior and Intergroup Contact Theory
The hypotheses being tested in this study were that increased personal and clinical
exposure, decreased transphobia, increased empathetic attitudes, and increased self-efficacy
related to transgender patient care (fewer barriers and more facilitators) would increase the odds
of being willing to provide routine care, continue HT, and initiate HT. Results indicate that
personal exposure - specifically, having ever met a transgender person - increased the odds of
being willing to provide both routine care and continue HT. In terms of clinical exposure,
having provided care in general to transgender patients was not predictive, but ever having
continued HT for a transgender patient increased the odds of being willing to do so in the future.
This suggests that intergroup contact theory did add substantively add to the theoretical
framework for the study, and potentially that personal contact is more salient than clinical
contact. This may be explained by intergroup contact theory’s principle that having equal status
among individuals is important in fostering positive interactions (Gierman-Riblon & Salloway,
2013; Pettigrew, 1998). The unequal power dynamic between healthcare providers and their
patients may be particularly relevant when it comes to transgender patients who are put in the
position of having to educate their providers instead of the other way around (Poteat et al.,
2013a).
According to the Theory of Planned Behavior, attitudes (in this study, empathetic
attitudes towards transgender patients), subjective norms (transphobia), and perceived
behavioral control (self-efficacy) should all contribute to behavioral intention (willingness).
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Although empathy was associated with willingness to provide routine care and continue HT in
the expected direction in the bivariate analyses (i.e., those who were willing to provide care had
higher empathy scores), empathy was not a significant contributor to any of the multivariate
models. Transphobia contributed significantly only to the model predicting willingness to
continue HT, and in the expected direction – transphobia decreased the odds of willingness to
continue HT. In the general population, negative attitudes towards transgender people are
correlated with traditional ideas about gender and binary gender beliefs (Norton & Herek,
2013). It may be that more transphobic providers may be willing to provide routine care to
transgender patients, but not be willing to participate in the gender transition process due to
their personal beliefs about gender.
Self-efficacy proved to be important in each of the models: feeling capable of providing
routine care significantly increased the odds of being willing to do so, and being familiar with
any HT regimen increased the odds of being willing to both continue and initiate HT. Only one
barrier was important to willingness, but not in the expected direction: providers who reported
barriers around being able to procure insurance reimbursement for transgender health care were
more likely to be willing to initiate HT. This may be accounted for by the feedback loops
included in the Theory of Planned Behavior: the relationship between behavior/intention and
behavioral control is often bidirectional (Ajzen, 1991). It may be that only providers who were
interested in providing HT or had done so in the past were aware of potential barriers such as
insurance reimbursement issues.
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Study Implications
Medical Education
Improving transgender care-related self-efficacy, particularly feelings of capability and
familiarity with hormone regimens, should begin with including transgender health content in
both medical and nursing education curricula. A recent study found that the median time spent
on LGBT health in medical school curricula in Canada and the U.S. was 5 hours total. However,
only 30.3% of medical schools report spending any time at all on the topic of gender
transitioning and 34.8% cover sex reassignment surgery (Obedin-Maliver et al., 2011). In
addition, only 16% of allopathic medical schools in the United States provide what they identify
as comprehensive LGBT training for faculty physicians who are teaching medical students and
residents; over half provide no such training for faculty physicians (Khalili, Leung, & Diamant,
2015). For the minority of programs that do provide faculty training, there is no information
available on how much time or content is devoted specifically to gender identity issues or
transgender health.
There is evidence that simply adding transgender health topics to medical education and
training can be effective. Although willingness to provide care was not assessed, one recent
study found that delivering a single transgender health lecture as part of a family medicine
clerkship for medical students resulted in increased knowledge, positive attitudes, and
perceived skills for participants compared to students that did not receive the transgender health
lecture (Dowshen, Nguyen, Gilbert, Feiler, & Margo, 2014). Another recent study found that
adding just a one-hour lecture on transgender health and hormone treatment significantly
increased medical students’ comfort and willingness to treat transgender patients (Safer &
Pearce, 2013).
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Given the relationship between personal contact with transgender individuals and
willingness to provide care in this study, it may be even more beneficial to incorporate personal
exposure into medical training. In fact, a recent intervention trial informed by intergroup contact
theory found that a transgender speaker panel was significantly more effective in reducing
transphobia than a traditional lecture about transgender-specific topics (Walch et al., 2012).
Others have suggested that higher level changes could be effective in improving
healthcare providers’ competency and knowledge around LGBT health, including adding
questions about transgender health to national exams (such as the United States Medical
Licensing Examination) or requiring transgender health-related training or other requirements
as part of healthcare accreditation processes (Obedin-Maliver et al., 2011). This may begin to
change norms around responsibility and capability for providing transgender care. With respect
to women’s health care providers, Obedin-Maliver and colleagues explain, “Expanding our
practices to provide for transgender individuals will not diminish our care of cisgender women,
but rather will extend our services to others in need. Let’s make the pie bigger and apply our
prior baking lessons; let’s bring our knowledge, skills, and passion for advocacy to a
marginalized group while redefining ourselves as reproductive health physicians” (ObedinMaliver, 2015, p. 110).
Social Work and Social Justice
The transgender population is arguably one of the most marginalized groups in the
United States, and social workers have an ethical obligation to reduce discrimination and
oppression of vulnerable groups, including those marginalized due to their gender identity
(National Association of Social Workers, 2008). Results of this study indicate that some
providers are not willing to provide even routine or basic care to transgender individuals, and
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many are not willing to continue HT, although this service is well within the purview of these
medical specialties. Efforts should be made in both social work education and social work
practice in order to advocate for transgender individuals seeking healthcare.
Social work education. Social work education has long placed an emphasis on
developing cultural competence among social work practitioners, first with an emphasis on
racial and ethnic diversity and then expanding to focus on competence related to a number of
minority or cultural groups – including sexual minorities. A number of studies have assessed
the climate of social work education related to LGBT issues in general. One recent study found
little evidence of negative attitudes towards LGBT people among a national sample of graduate
social work faculty (Woodford, Brennan, Gutiérrez, & Luke, 2013), although negative attitudes
were endorsed more frequently when the sample included non-graduate faculty and was limited
to heterosexual respondents (Chonody, Woodford, Brennan, Newman, & Wang, 2014). Despite
exposure to cultural competence training, social work students still report experiencing
homophobia in social work classroom settings (Dentato et al., 2016) as well as conflict between
religious social work students and lesbian, gay, and bisexual social work students (Joslin,
Dessel, & Woodford, 2016).
To date, there have been no published studies of social work student – or faculty attitudes towards or experience with transgender clients or individuals specifically.
Unpublished data indicate that MSW students in one Midwestern university have similar or
greater levels of personal exposure to transgender individuals compared to the healthcare
providers in this study; 12.9% of MSW students reported having transgender friends and 0.9%
reported having transgender family members (Jaffee, Dessel, & Woodford, 2013). Further
research is needed to determine the level of bias that social work students exhibit towards
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gender minorities and how to mitigate such bias so that social workers can serve as advocates
for this marginalized community.
Social work practice. As case managers, therapists, and critical members of medical
teams, social workers often serve an advocacy role, including working to make sure that patients
receive needed medical, mental health, and support services, ensuring that patients receive fair
treatment, and taking into account a patient’s environment and level of social support when
providing services. The Patient Protection and Affordable Care Act’s (ACA) support of
integrated care (i.e., settings or systems that combine primary care and mental health care in
some way) has the potential to place more social workers in healthcare settings and ensure that
social workers play an integral role on healthcare teams (Davis et al., 2015).
However, despite increased integration among health professionals, physicians tend to
communicate primarily with other physicians, leaving allied health professionals – including
social workers – out of patient care decisions (Zwarenstein, Rice, Gotlib-Conn, Kenaszchuk, &
Reeves, 2013). One method of increasing collaboration among social workers, physicians, and
other healthcare providers is through the use of inter-professional education (IPE) or bringing
together various disciplines for training purposes. IPE is common in social work education
(Taylor, Coffey, & Kashner, 2015) but generally less valued by physicians and medical
students/residents (Kashner et al., 2016). Because the social work profession has long
championed IPE, social workers are in a unique position to advocate for this type of training
(Taylor et al., 2015), and in particular, to address head-on power inequities between physicians
and other professionals (Zwarenstein et al., 2013) that may limit collaboration and
communication that may be beneficial for vulnerable patients such as transgender individuals.
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In addition, social workers in private practice or other therapist roles who counsel
transgender clients through gender transition should be aware that not all primary care providers
are willing to initiate or even continue HT. Accordingly, social workers who are helping to
guide transgender individuals through the medical transition process should develop a network
of supportive providers, including those who are willing to provide routine care as well as HT.
Healthcare Policy
Legal protections for transgender Americans are generally lacking. Fewer than half of
states in the U.S. prohibit employment discrimination on the basis of gender identity, and even
fewer states prohibit housing discrimination based on gender identity (Human Rights
Campaign, 2016). However, the ACA does prohibit healthcare discrimination based on gender
identity, making it illegal for insurance companies to deny transgender patients coverage and
for transgender patients to be denied care – particularly from providers or systems who receive
federal (i.e., Medicaid or Medicare) funds (U.S. Department of Health and Human Services,
2010).
Provisions of the ACA may increase the proportion of transgender individuals who are
insured and seek access to both routine and transition care. Although the legal landscape is
changing for transgender patients, results of this study indicate that primary care providers’
training, experience, and personal values related to caring for transgender patients are lagging
behind. Providers may be legally required to care for transgender patients but may be unwilling
or feel incapable of doing so, particularly in the case of initiating or continuing hormone
therapy.
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Study Limitations
This study is not without limitations. Study limitations related to the cross-sectional
nature of the data, participant sample, sample size, and study instruments are described below.
Cross-Sectional Study
Causality cannot be established due to the cross-sectional nature of the data. However,
this is the first study to establish significant associations between willingness to provide care to
transgender individuals and both personal and clinical factors that may influence primary care
providers.
Participant Sample
This sample may be biased towards providers who are more sympathetic to or interested
in the transgender population or transgender health care. However, the use of incentives and
resulting high response rate may have helped to mitigate non-response bias in this study
(Massey & Tourangeau, 2013). Furthermore, healthcare providers may have over-reported their
willingness to treat transgender patients due to social desirability. Others have found that
physicians routinely overestimate their positive behaviors, such as adhering to medical
guidelines (Adams, Soumerai, Lomas, & Ross-Degnan, 1999). In addition, data were collected
in one Midwestern, urban/suburban health system. Results may not be generalizable to
healthcare providers in less integrated health systems, other parts of the country, or rural areas,
and further studies should assess unique factors that may impact other providers’ willingness
to deliver various types of care to the transgender population.
Sample Size
The relatively small sample size precluded the inclusion of all variables of interest in
the multivariate analyses. Larger and multisite studies are needed to not only replicate these
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findings, but to have adequate power to include all variables of interest. A larger sample may
lend itself not only to multi-level modeling to explore the influence of factors such as clinic
environment, but also structural equation modeling in order to determine significant pathways
between variables of interest and to more thoroughly test the theoretical model.
Instrument
With the exception of the empathetic attitudes and transphobia scales, questions used in
this study were modified or created specifically for use in this study. The reason for this is the
innovative nature of this work and dearth of literature and measures on which to draw. The
general confirmation of the study’s theoretical framework through the use of these created
measures lends some credence to the validity of the constructed measures. However, the
validity and reliability of most questions was not assessed or tested, so future studies should
seek to validate the new items and measures created and modified here. In addition, the 3-item
empathetic attitudes scale exhibited low internal consistency. This scale was included used
nonetheless due to the consistent association between the individual items and the outcome
variables.
Future Research
The results of this study suggest a number of potential next steps. First, it is unclear
what factors contribute to feelings of capability among providers. Future studies are needed,
perhaps qualitative studies, to assess why some providers feel more capable of delivering
routine care to transgender patients than others and how feelings of self-efficacy can best be
cultivated. In particular, it would be important to assess various aspects of perceived capability,
including not only medical knowledge but also perceptions of cultural competence and
confidence that providers can interact appropriately and respectfully with transgender patients.
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Furthermore, the focus of the survey and this study was a small segment of the
transgender continuum. This study focused on male-to-female patients or female-to-male
patients; i.e., those most likely to be interested in medical transition services such as hormone
therapy. What is also critical to understand is how providers feel about caring for gender-queer
and gender non-conforming patients, who may be subject to similar bias and discrimination but
who may be more difficult for providers to both identify and understand. Gender nonconforming or genderqueer individuals report avoiding or delaying medical care due to fear of
discrimination at higher rates than transgender-identified individuals (Harrison, Grant, &
Herman, 2012). Thus, it is critical to understand how providers perceive patients with diverse
gender identities and what type of barriers they may face to providing care to gender nonconforming patients who do not identify as transgender and who are not interested in medical
transition care.
Finally, although this study measured behavioral intentions, actual provider behavior
was not measured. Although intentions are often highly correlated with behavior, they are
generally far from perfectly correlated (Kim & Hunter, 1993). Future studies should
systematically assess how often providers accept transgender patients versus referring them to
other providers or simply refusing them both routine and transition care.
Conclusions
This is the first study to examine whether practicing primary care providers are willing
to provide routine care and hormone therapy to transgender patients. Although most primary
care physicians and other providers are willing to provide routine care to this patient population,
far fewer are willing to provide HT, for a number of reasons which may include both clinical
experience and personal reasons. Social workers can help transgender individuals navigate a
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healthcare system where they may encounter providers who are not willing to treat them as well
as advocate for better access to care for the transgender population.
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APPENDIX: PROVIDER SURVEY
Caring for Transgender Patients
This survey is both confidential and voluntary. Results will only be reported in aggregate, and
you can stop participating at any time. We are interested in your opinions about and experiences
with transgender patients and their medical care.
The following questions are about you. Please choose one answer unless otherwise indicated.
How many years have you been in practice since completing your training?
a) I’m a resident/fellow
b) 0-4
c) 5-9
d) 10-14
e) 15-19
f) 20 or more
1. What is your current age? ___ years
2. Where did you attend high school?
a) North America or the Caribbean
b) Middle East
c) Central or South America
d) Asia
e) Africa
f) Europe
g) Australasia
3. Which of the following race/ethnicity groups best describes you (check all that apply):
a) African American or Black
b) Asian American / Pacific Islander
c) Latina/o or Hispanic
d) Native American or American Indian
e) White or Caucasian
f) Other _____________
4. What is your biological sex?
a) Female
b) Male
c) Other: __________
5. Do you identify primarily as a:
a) Woman
b) Man
c) Other: ______________
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6. Do you identify primarily as:
d) Heterosexual
e) Gay
f) Lesbian
g) Bisexual
h) Other: ______________
7. What is your primary religious identity?
a) Agnostic/Atheist
b) Christian
c) Jewish
d) Muslim
e) Hindu
f) Other _____________
9. To what extent do you consider yourself a religious person?
a) Very religious
b) Moderately religious
c) Slightly religious
d) Not religious at all
10. How would you describe your political views?
a) Very liberal
b) Liberal
c) Moderate/middle of the road
d) Conservative
e) Very conservative
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The next questions are about your personal and clinical experience with transgender
individuals.
Before answering the following questions, please consider these definitions:
TERM
Gender Identity

Transgender Person

Female-to-Male
Male-to-Female

DEFINITION
A person's innate, deeply felt psychological identification as a man,
woman or some other gender, which may or may not correspond to
the sex assigned to them at birth
An individual whose gender identity does not conform to what is
typically associated with the legal and biological sex to which they
were assigned at birth.
A person who was assigned female at birth but identifies as male
A person who was assigned male at birth but identifies as female

11. About how many hours of formal education about transgender health have you had in a medical
educational setting (i.e, medical school, nursing or PA school, residency, CME, CEU, etc.)?
___ hours
12. About how many hours of informal education (i.e., reading, self-directed learning, etc.) about
transgender health have you had?
___ hours
13. Have you ever met a transgender person?
14. Do you have any acquaintances or colleagues who are transgender?
15. Do you have any close friends or family who are transgender?
16. Have you ever newly prescribed hormone therapy for a transgender
patient?
17. Have you ever continued a hormone therapy regimen initiated by another
provider for a transgender patient?
18. Have you ever been involved in a patient’s transition process (e.g.
referrals, lab monitoring, transition-related counseling, etc.)?
19. In the past 5 years, how many transgender patients have you cared for?

Yes
Yes
Yes
Yes

No
No
No
No

Yes

No

Yes

No
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Below you will find a list of statements. Next to each item, please indicate how much you agree
with each statement, using the following scale.
Routine Medical Care for Transgender Patients

20. I am
capable of
providing
routine
medical care
to transgender
patients.
21. I am
willing to
provide
routine
medical care
to male-tofemale
transgender
patients.
22. I am
willing to
provide
routine
medical care
to female-tomale
transgender
patients.
23. I am
willing to
perform PAP
smears for
female-tomale patients.
24. I am
willing to
perform
digital rectal
exams for
male-tofemale
patients.

Strongly
disagree
1

Disagree

Neutral

2

Somewhat
disagree
3

Agree

4

Somewhat
agree
5

6

Strongly
agree
7

Not
Applicable
8

1

2

3

4

5

6

7

8

1

2

3

4

5

6

7

8

1

2

3

4

5

6

7

8

1

2

3

4

6

7

8

5
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Cross-Sex Hormone Therapy for Transgender Patients

25. I am familiar
with the hormonal
regimens for
female-to-male
gender transition.
26. I am familiar
with the hormonal
regimens for
male-to-female
gender transition.
27. I would
continue a gender
transition
hormone therapy
regimen initiated
by another
provider.
28. I am willing to
initiate hormone
therapy for
female-to-male
patients.
29. I am willing to
initiate hormone
therapy for male
to-female
patients.

Strongly
disagree
1

Disagree

1

2

3

4

1

2

3

1

2

1

2

2

Somewhat Neutral Somewhat
disagree
agree
3
4
5

Agree
6

Strongly
agree
7

Not
Applicable
8

5

6

7

8

4

5

6

7

8

3

4

5

6

7

8

3

4

5

6

7

8

73
Next to each item, please indicate your level of agreement with each statement, using the
following scale.

30. My colleagues
discourage me from caring
for transgender patients.
31. My administration
discourages me from caring
for transgender patients.
32. Not knowing how to bill
for services for transgender
people discourages me from
taking care of transgender
patients.
33. Lack of insurance
reimbursement discourages
me from taking care of
transgender patients
34. My lack of familiarity
with guidelines for
transition care for
transgender patients
discourages me from caring
for transgender patients.
35. My lack of training in
transgender-specific care
discourages me from caring
for transgender patients
36. My lack of exposure to
transgender patients
discourages me from
accepting transgender
patients.
37. Lack of knowledge
about transgender patients
among my office staff,
medical assistants, and/or
nursing staff discourages
me from caring for
transgender patients
38. My religious beliefs
discourage me from caring
for transgender patients.

Strongly
disagree
1

Disagree

6

Strongly
agree
7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

2

Somewhat Neutral Somewhat
disagree
agree
3
4
5

Agree

39. If a transgender patient in need of specialty transition care presented to my care today, I would be
able to provide an appropriate referral to a local:
a)
b)
c)
d)

endocrinologist specializing in transgender care (Yes/No)
surgeon specializing in transgender care (Yes/No)
mental health provider specializing in transgender care (Yes/No)
advocacy or social service agency for the transgender community (Yes/No)
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The following questions pertain to your attitudes and feelings towards transgender patients.
Please mark the number on the scale below that indicated your level of agreement or
disagreement with each statement.

40. It is necessary for a
healthcare practitioner to be
able to comprehend
someone else’s experiences.
41. I will not allow myself
to be influenced by
someone’s feelings when
determining the best
treatment.
42. I am able to value
someone else’s point of
view.
43. Considering someone’s
feelings is not necessary to
provide patient-centered
care.

Strongly
disagree
1

Disagree

1

2

3

4

1

2

3

1

2

3

2

Somewhat Neutral Somewhat
disagree
agree
3
4
5

Agree
6

Strongly
agree
7

5

6

7

4

5

6

7

4

5

6

7
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Below you will find a list of statements. Next to each item, please indicate your level of
agreement with each statement, using the following scale.

44. When I meet someone it
is important for me to be
able to identify them as a
man or a woman.
45. I believe that the
male/female dichotomy is
natural.
46. I am uncomfortable
around people who don’t
conform to traditional gender
roles, e.g., assertive women
or emotional men.
47. I believe that a person
can never change their
gender.
48. A person’s genitalia
define what gender they are,
e.g., a penis defines a person
as being a man, a vagina
defines a person as being a
woman.
49. I think there is something
wrong with a person who
says that they are neither a
man nor a woman.
50. I would be upset if
someone I’d known for a
long time revealed to me that
they used to be another
gender.
51. I avoid people on the
street whose gender is
unclear to me.

Strongly
disagree
1

Disagree

Neutral

2

Somewhat
disagree
3

Agree

4

Somewhat
agree
5

6

Strongly
agree
7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7
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Please indicate whether you believe that the following statements are true or false.
52. Transgender patients using cross-sex hormones should be monitored for endocrine changes every 3
months in the first year and then once per year for the duration of hormone use.
53. The best way to assess which pronoun to use (i.e., he or she) when addressing a transgender patient
is to use the sex listed in their medical record.
54. In most cases, Medicaid will pay for gender transition surgery (Gender Reassignment Surgery).
55. The diagnostic criteria for Gender Dysphoria according to the World Professional Association for
Transgender Health (WPATH) states that symptoms must be present for at least two years.
56. Failure of treatment with SSRI/SNRIs is required prior to genital surgery.
57. Mental health assessment is needed prior to genital surgery.
58. In most cases, 12 months of hormone therapy is expected prior to genital surgery.
59. Current guidelines for cross-sex hormone treatment for transgender patients are based on a number
of randomized controlled trials (Level A evidence) .
60. After mastectomy, female-to-male transgender individuals should continue being screened
regularly for breast cancer.
61. A transgender man is someone who was assigned female at birth but identifies as male.
62. Transgender people are at increased risk for suicidal ideation.
63. Transgender individuals are no more likely to be unemployed than the rest of the population.
64. Completing this survey has increased my awareness of transgender people’s healthcare needs.
Strongly agree

Agree somewhat

Neutral or
undecided

Disagree
somewhat

Strongly disagree

65. I am interested in receiving further training about:
transition care for transgender patients (Yes/No)
issues in routine care of transgender patients (Yes/No)
how to provide culturally sensitive care to transgender patients (Yes/No)
66. Do you have any additional comments or thoughts about this survey or treating transgender
patients that you would like to share with the research team?

Thank you for completing this survey!
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Please provide your name and address so that we can mail your gift card to you. This information will
be stored separately from your survey answers and will not be used for any other purpose.
Name:
Mailing Address:
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Transgender individuals report being denied healthcare services, but very little is known
about primary care providers’ (PCP) willingness to deliver either routine or transition care to
the transgender community. The purpose of this study is to examine PCP willingness to deliver
routine care, continue a hormone therapy (HT) regimen initiated by another provider, and
initiate HT for transgender patients using a theoretical framework informed by the Theory of
Planned Behavior and Intergroup Contact Theory. The study sample was all family medicine,
internal medicine, and women’s health providers in a large integrated Midwestern health
system. Eligible participants were emailed a unique link to an online survey assessing clinical
and personal exposure to transgender individuals, empathetic attitudes, transphobia, selfefficacy, willingness to deliver care, and socio-demographics. While the majority of providers
were willing to provide routine care to transgender patients, only half (53%) were willing to
continue HT and even fewer (22%) were willing to initiate HT. Factors that increased the odds
of willingness to provide routine care included personal exposure to transgender individuals
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and feelings of capability. Being Christian or Jewish, personal and clinical exposure to
transgender individuals, decreased transphobia, and familiarity with HT regimens increased the
odds of willingness to continue HT. Familiarity with HT and reporting insurance barriers
increased the odds of willingness to initiate HT. Both cultural and policy shifts and provisions
of the ACA will increase access to care for transgender patients; in order for healthcare systems
to adapt, both medical education and social work education should address cultural competence
issues around transgender care.
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